Citations

Clear

382 citation(s) found for "Li, Man".

Sex differences in GABAA receptor subunit transcript expression are mediated by genotype in subjects with alcohol‐related cirrhosis of the liver
Ashton, Madeline K., Rueda, André Veloso Lima , Ho, Ada Man‐Choi , Aizin, Noradibah Arina Binte M. Noor, Sharma, Hansa , Dodd, Peter R. , Stadlin, Alfreda , Camarini, Rosana , Rueda, André V L , Ho, Ada M-C , Ashton, Madeline K.

Mayo Clinic

Genes, Brain and Behavior | March 18, 2022 | Volume: 21 | Issue: 4 | Pages: No page available

10.1111/gbb.12785 | PMID 35301805 Get It

AbstractMale and female human subjects show contrasting propensities to misuse drugs of addiction, including alcohol. These differences lead to different psychological and neurological consequences, such as the likelihood of developing dependence. The pattern and extent of brain damage in alcohol‐use disorder cases also varies with comorbid disease. To explore mechanisms that might underlie these outcomes, we used autopsy tissue to determine mRNA transcript expression in relation to genotype for two GABAA receptor subunit genes. We used quantitative Real‐Time PCR to measure GABRA6 and GABRA2 mRNA concentrations in dorsolateral prefrontal and primary motor cortices of alcohol‐use disorder subjects and controls of both sexes with and without liver disease who had been genotyped for these GABAA receptor subunit genes. Cirrhotic alcohol‐use disorder cases had significantly higher expression of GABRA6 and GABRA2 transcripts than either controls or non‐cirrhotic alcohol‐use disorder cases. Differences were observed between sexes, genotypes and brain regions. We show that sex differences in subjects with GABRA6 and GABRA2 variants may contribute to differences in susceptibility to alcohol‐use disorder and alcohol‐induced cirrhosis.
Preclinical evaluation of LCK as a novel therapeutic target in YAP-activated and FGFR2-altered cholangiocarcinoma.
Buckarma, EeeLN H. , Werneburg, Nathan W., Watkins, Ryan , Guo, Yi , Wang, Juan , O’Brien, Daniel R. , Buijsman, Rogier C. , Vu, Diep, Man, Jos de , Truty, Mark J. , Conboy, Caitlin B. , Yonkus, Jennifer A. , Mun, Dong‐Gi , Vu, Diep, Ilyas, Sumera I. , Borad, Mitesh J. , Pandey, Akhilesh , Gores, Gregory J. , Smoot, Rory L.

Mayo Clinic

Journal of Clinical Oncology | January 19, 2022 | Volume: 40 | Issue: 4_suppl | Pages: 463-463

10.1200/jco.2022.40.4_suppl.463 Get It

463 Background: Molecularly targeted therapy is gaining traction in cholangiocarcinoma with the first FDA approval of a targeted agent in 2020, the FGFR inhibitor pemigatinib. Yet response rates and efficacy are modest, and most cholangiocarcinoma patients still lack targeted therapy options. The hippo pathway effector, YAP, is an oncogene that is activated in the majority of cholangiocarcinoma, yet attempts to develop YAP inhibitors have not yet been clinically successful. Recently, we described a novel mechanism of YAP regulation, via tyrosine phosphorylation by the Src-family kinase LCK. Therefore we hypothesized that LCK inhibition by may be therapeutic in cholangiocarcinoma through suppression of YAP activity. Methods: NTRC 0652-0 is a novel tyrosine kinase inhibitor with specificity for LCK. In vitro pharmacodynamics were defined. In cholangiocarcinoma cells, specificity for LCK inhibition was determined by mass spectrometry-based unbiased analysis of the tyrosine phosphoproteome following treatment with NTRC 0652-0 or genetic deletion of LCK. YAP phosphorylation and cotranscriptional activity, cell viability, and apoptosis were assessed. A panel of eight cholangiocarcinoma patient derived organoids (PDO) were characterized and tested for sensitivity to NTRC 0652-0. Two patient-derived xenograft (PDX) models bearing FGFR2-rearrangements were utilized for in vivo assessment of pharmacokinetics, toxicity, and efficacy. Results: NTRC 0652-0 demonstrated selectivity for LCK inhibition in vitro and in cholangiocarcinoma cells. NTRC 0652-0 treatment led to YAP inhibition and apoptotic cell death in cholangiocarcinoma cell lines, associated with inhibition of MCL1 expression. PDOs demonstrated variable sensitivity to NTRC 0652-0, correlated with basal YAP tyrosine phosphorylation and drug-induced suppression of YAP co-transcriptional activity. FGFR2-altered cholangiocarcinoma was also identified as a subset with enrichment of YAP target genes. Cells from an FGFR2-altered PDX were sensitive to NTRC 0652-0 despite being primarily resistant to pemigatinib. In two PDX models of FGFR2-altered cholangiocarcinoma, daily oral treatment with NTRC 0652-0 inhibited YAP tyrosine phosphorylation, and resulted in stable plasma and tumor drug levels, acceptable toxicity, and significantly decreased tumor growth. Conclusions: A novel LCK inhibitor, NTRC 0652-0, reduced YAP signaling and demonstrated preclinical efficacy in multiple patient-derived models of cholangiocarcinoma. LCK is a novel therapeutic target in cholangiocarcinoma, and YAP activation or FGFR2-alteration are potential biomarkers for response.
Radial Head Prosthetic Replacement in Adolescents: A Report of 5 Cases
Rotman, Dani , Liévano, Jorge Rojas , O’Driscoll, Shawn W. , Rojas Lievano, Jorge, Kwak, Jae-Man, O'Driscoll, Shawn W., Fitzsimmons, James S , Kwak, Jae‐Man , Lievano, Jorge Rojas

Mayo Clinic

Journal of Pediatric Orthopaedics | December 7, 2021 | Volume: 42 | Issue: 2 | Pages: 109-115

10.1097/bpo.0000000000002030 | PMID 34873116 Get It

Background: The management of severe radiocapitellar joint pathologies in young patients is challenging. Radial head arthroplasty (RHA) is a treatment option in the adult population, but most surgeons avoid implementing it in younger patients, and there are no published results for patients younger than 16 years. Methods: Our retrospective cohort describes 5 patients (4 male 1 female) who underwent cementless modular RHA at an average age of 14 years (range: 13 to 15). The preoperative diagnoses were post-traumatic radiocapitellar incongruity and arthrosis because of previous Salter-Harris type 3 or 4 fractures of the radial head in 3 cases; and axial instability of the forearm following failed radial head excision in 2 cases. Because of the complexity of the elbow pathology in these cases, all underwent concomitant procedures including: contracture release (5 cases), corrective ulnar osteotomy (2 cases), distal ulnar shortening osteotomy, excision of radioulnar synostosis, microfracture of the capitellum, and partial excision of the medial triceps (1 case each). Collected data included patient-reported outcomes, visual analog scale pain score at rest and during physical activity and radiographic assessment of arthritis and prosthesis loosening. Results: Average clinical follow-up was 8 years (range: 3 to 13). All 5 patients were pain-free at rest, and 3 reported moderate elbow pain (visual analog scale: 5 to 6) with physical activity. At an average radiographic follow-up of 3 years (range: 0.5 to 5), 3 patients showed mild progression of elbow arthrosis, but there were no signs of progressive capitellar erosion or implant loosening. Only 1 complication was noted—development of heterotopic ossification in 1 patient, which required open heterotopic ossification excision and contracture release 2 years following the RHA. None of the patients required prosthesis revision or removal. Conclusion: RHA was successful in improving pain and axial forearm stability in this very small series of adolescent patients. Concerns regarding long-term longevity and complications still exist. Considering the lack of other reliable treatment options, RHA may be indicated in this challenging patient population. Level of Evidence: Level IV: therapeutic study—case series.
A Man with Exertional Dyspnea and Diffuse Bronchial Wall Thickening
Stultz, Benjamin R. , Ryu, Jay H. , Edell, Eric S., Kelm, Diana J. , Ryu, Jay H , Stultz, Benjamin R. , Edell, Eric S., Kelm, Diana J

Mayo Clinic

Annals of the American Thoracic Society | December 1, 2021 | Volume: 18 | Issue: 12 | Pages: 2084-2089

10.1513/annalsats.202105-545cc | PMID 34851243 Get It

Clinical Reasoning: A 31-Year-Old Man With Sequential Vision Loss
Fortes, Blake, Chen, John J., Bhatti, M. Tariq, Chen, John J. , Fortes, Blake H. , Chen, John J , Fortes, Blake H , Chen, John J., Bhatti, M. Tariq

Mayo Clinic

Neurology | November 19, 2021 | Volume: 98 | Issue: 4 | Pages: 163-169

10.1212/wnl.0000000000013084 | PMID 34799463 Get It

Ultrasonographic Measurement of Elbow Varus Laxity With a Sequential Injury Model of the Lateral Collateral Ligament–Capsular Complex
Rotman, Dani , Liévano, Jorge Rojas , O’Driscoll, Shawn W. , Kwak, Jae-Man, Fitzsimmons, James S. , O'Driscoll, Shawn W., Fitzsimmons, James S , Kwak, Jae‐Man , Lievano, Jorge Rojas

Mayo Clinic

Orthopaedic Journal of Sports Medicine | November 10, 2021 | Volume: 9 | Issue: 11 | Pages: No page available

10.1177/23259671211048941 | PMID 34778473 Get It

Background: There is no consensus how to determine the varus laxity due to the LCL injury using the ultrasonography. There is a risk of lateral collateral ligament injury during or after arthroscopic extensor carpi radialis brevis release for tennis elbow. The equator of the radial head has been suggested as a landmark for the safe zone to not increase this risk; however, the safe zone from the intra-articular space has not been established. Hypothesis: Increased elbow varus laxity due to lateral collateral ligament–capsular complex (LCL-cc) injury could be assessed reliably via ultrasound. Study Design: Descriptive laboratory study. Methods: Eight cadaveric elbows were evaluated using a custom-made machine allowing passive elbow flexion under gravity varus stress. The radiocapitellar joint (RCJ) space was measured via ultrasound at 30° and 90° of flexion during 4 stages: intact elbow (stage 0), release of the anterior one-third of the LCL-cc (stage 1), release of the anterior two-thirds (stage 2), and release of the entire LCL-cc (stage 3). Two observers conducted the measurements separately, and the mean RCJ space in the 3 LCL-cc injury models (stages 1-3) at both flexion angles was compared with that of the intact elbow (stage 0). We also compared the measurements at 30° versus 90° of flexion. Results: At 30° of elbow flexion, the RCJ space increased 2 mm between stages 0 and 2 (95% confidence interval [CI], 1-3 mm; P < .01) and 4 mm between stages 0 and 3 (95% CI, 2-5 mm; P < .01). At 90° of elbow flexion, the RCJ space increased 1 mm between stages 0 and 2 (95% CI, 1-2 mm; P < .01) and 2 mm between stages 0 and 3 (95% CI, 2-3 mm; P < .01). Conclusion: Elbow varus laxity under gravity stress can be reliably assessed via ultrasound by measuring the RCJ space. Clinical Relevance: Because ultrasonographic measurement of the RCJ space can distinguish the increasing varus laxity seen with release of two-thirds or more of the LCL-cc, the anterior one-third of the LCL-cc, based on the diameter of the radial head, can be considered the safe zone in arthroscopic extensor carpi radialis brevis release for tennis elbow.
Remote Limb Ischemic Postconditioning Protects Against Ischemic Stroke by Promoting Regulatory T Cells Thriving
Yu, Hai‐Han, Ma, Xiao‐Tong , Ma, Xue, Ma, Xue, Chen, Man, Chu, Yun‐Hui, Wu, Long‐Jun , Wang, Wei, Qin, Chuan, Tian, Dai‐Shi , Wu, Long-Jun , Tian, Dai-Shi , Yu, Hai‐Han, Ma, Xiao‐Tong , Ma, Xue, Ma, Xue, Chen, Man, Chu, Yun‐Hui, Wang, Wei, Qin, Chuan

Mayo Clinic

Journal of the American Heart Association | November 2, 2021 | Volume: 10 | Issue: 22 | Pages: No page available

10.1161/jaha.121.023077 | PMID 34726065 Get It

Background Remote limb ischemic postconditioning (RLIPoC) has been demonstrated to protect against ischemic stroke. However, the underlying mechanisms of RLIPoC mediating cross‐organ protection remain to be fully elucidated. Methods and Results Ischemic stroke was induced by middle cerebral artery occlusion for 60 minutes. RLIPoC was performed with 3 cycles of 10‐minute ischemia followed by 10‐minute reperfusion of the bilateral femoral arteries immediately after middle cerebral artery reperfusion. The percentage of regulatory T cells (Tregs) in the spleen, blood, and brain was detected using flow cytometry, and the number of Tregs in the ischemic hemisphere was counted using transgenic mice with an enhanced green fluorescent protein‐tagged Foxp3. Furthermore, the metabolic status was monitored dynamically using a multispectral optical imaging system. The Tregs were conditionally depleted in the depletion of Treg transgenic mice after the injection of the diphtheria toxin. The inflammatory response and neuronal apoptosis were investigated using immunofluorescent staining. Infarct volume and neurological deficits were evaluated using magnetic resonance imaging and the modified neurological severity score, respectively. The results showed that RLIPoC substantially reduced infarct volume, improved neurological function, and significantly increased Tregs in the spleen, blood, and ischemic hemisphere after middle cerebral artery occlusion. RLIPoC was followed by subsequent alteration in metabolites, such as flavin adenine dinucleotide and nicotinamide adenine dinucleotide hydrate, both in RLIPoC‐conducted local tissues and circulating blood. Furthermore, nicotinamide adenine dinucleotide hydrate can mimic RLIPoC in increasing Tregs. Conversely, the depletion of Tregs using depletion of Treg mice compromised the neuroprotective effects conferred by RLIPoC. Conclusions RLIPoC protects against ischemic brain injury, at least in part by activating and maintaining the Tregs through the nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide hydrate pathway.
S2631 Porphyria Cutanea Tarda, Type 2, in a Man With a Novel UROD Mutation
Soufleris, Stephen J. , Moore, Michelle E., Phillips, John D. , Netzel, Brian C., Rudnick, Sean, Faust, Denise, Bonkovsky, Herbert L. , Moore, Michelle

Mayo Clinic

American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S1104-S1104

10.14309/01.ajg.0000784056.36506.de Get It

Insulin secretion and action and the response of endogenous glucose production to a lack of glucagon suppression in nondiabetic subjects
Adams, J.D. , LAURENTI, MARCELLO C. , Wismayer, Daniel Schembri, Bailey, Kent R. , Man, Chiara Dalla , Vella, Adrian , Adams, Jon D, Egan, Aoife M. , Schembri Wismayer, Daniel, Dalla Man, Chiara , Vella, Adrian , Cobelli, Claudio

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | October 18, 2021 | Volume: 321 | Issue: 5 | Pages: E728-E736

10.1152/ajpendo.00284.2021 | PMID 34658253 Get It

In prediabetes, anthropometric characteristics as well as insulin action do not alter the hepatic response to glucagon. The postprandial suppression or lack of suppression of glucagon secretion is an important factor governing postprandial glucose tolerance independent of insulin secretion.